(CF) CF Industries Holdings - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1252691001
Stock: Ammonia, Urea, Uan, Fertilizer, Chemicals
Total Rating 68
Risk 78
Buy Signal 0.45
| Risk 5d forecast | |
|---|---|
| Volatility | 30.7% |
| Relative Tail Risk | 0.40% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.08 |
| Alpha | 27.60 |
| Character TTM | |
|---|---|
| Beta | 0.218 |
| Beta Downside | 1.250 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.16% |
| CAGR/Max DD | 0.38 |
EPS (Earnings per Share)
Revenue
Description: CF CF Industries Holdings February 27, 2026
CF Industries Holdings (NYSE: CF) manufactures and sells hydrogen-based nitrogen products-including anhydrous ammonia, granular urea, and UAN-serving cooperatives, distributors, traders and industrial users across North America, Europe and other markets. The firm operates through five segments (Ammonia, Granular Urea, UAN, AN, and Other) and also offers diesel exhaust fluid, nitric acid and aqua-ammonia.
In its latest quarter (Q4 2025), CF reported adjusted EBITDA of $1.2 billion, a 9% YoY increase, driven by higher fertilizer prices and a 4% rise in ammonia production capacity to 9.8 million tons. Net income rose to $540 million, while cash flow from operations reached $820 million, supporting a $1.5 billion share repurchase program announced in January 2026.
Key sector drivers include a 6% year-over-year growth in global nitrogen fertilizer demand, buoyed by rising grain prices and expanding agricultural acreage in emerging markets, and the ongoing volatility of natural-gas input costs, which remain the single largest cost component for nitrogen producers. For a deeper dive into CF’s valuation metrics and scenario analysis, you might explore the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 1.46b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA -0.21 > 1.0 |
| NWC/Revenue: 29.62% < 20% (prev 28.67%; Δ 0.94% < -1%) |
| CFO/TA 0.20 > 3% & CFO 2.75b > Net Income 1.46b |
| Net Debt (1.97b) to EBITDA (3.29b): 0.60 < 3 |
| Current Ratio: 3.37 > 1.5 & < 3 |
| Outstanding Shares: last quarter (156.1m) vs 12m ago -10.03% < -2% |
| Gross Margin: 41.28% > 18% (prev 0.35%; Δ 4093 % > 0.5%) |
| Asset Turnover: 51.42% > 50% (prev 44.08%; Δ 7.34% > 0%) |
| Interest Coverage Ratio: 15.45 > 6 (EBITDA TTM 3.29b / Interest Expense TTM 155.0m) |
Altman Z'' 3.69
| A: 0.15 (Total Current Assets 2.98b - Total Current Liabilities 887.0m) / Total Assets 14.09b |
| B: 0.27 (Retained Earnings 3.87b / Total Assets 14.09b) |
| C: 0.17 (EBIT TTM 2.39b / Avg Total Assets 13.78b) |
| D: 0.61 (Book Value of Equity 3.87b / Total Liabilities 6.31b) |
| Altman-Z'' Score: 3.69 = AA |
Beneish M -3.14
| DSRI: 1.01 (Receivables 488.0m/404.0m, Revenue 7.08b/5.94b) |
| GMI: 0.84 (GM 41.28% / 34.72%) |
| AQI: 0.96 (AQ_t 0.28 / AQ_t-1 0.29) |
| SGI: 1.19 (Revenue 7.08b / 5.94b) |
| TATA: -0.09 (NI 1.46b - CFO 2.75b) / TA 14.09b) |
| Beneish M-Score: -3.14 (Cap -4..+1) = AA |
What is the price of CF shares?
As of March 04, 2026, the stock is trading at USD 106.30 with a total of 5,439,226 shares traded.
Over the past week, the price has changed by +10.60%, over one month by +15.53%, over three months by +34.78% and over the past year by +39.50%.
Over the past week, the price has changed by +10.60%, over one month by +15.53%, over three months by +34.78% and over the past year by +39.50%.
Is CF a buy, sell or hold?
CF Industries Holdings has received a consensus analysts rating of 3.10.
Therefor, it is recommend to hold CF.
- StrongBuy: 1
- Buy: 1
- Hold: 18
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the CF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 96.7 | -9% |
| Analysts Target Price | 96.7 | -9% |
CF Fundamental Data Overview March 04, 2026
P/E Trailing = 11.6276
P/E Forward = 11.4679
P/S = 2.2965
P/B = 3.2018
P/EG = 3.4458
Revenue TTM = 7.08b USD
EBIT TTM = 2.39b USD
EBITDA TTM = 3.29b USD
Long Term Debt = 3.21b USD (from longTermDebt, last quarter)
Short Term Debt = 110.0m USD (from shortTermDebt, last quarter)
Debt = 3.95b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.97b USD (from netDebt column, last quarter)
Enterprise Value = 18.23b USD (16.27b + Debt 3.95b - CCE 1.98b)
Interest Coverage Ratio = 15.45 (Ebit TTM 2.39b / Interest Expense TTM 155.0m)
EV/FCF = 10.12x (Enterprise Value 18.23b / FCF TTM 1.80b)
FCF Yield = 9.88% (FCF TTM 1.80b / Enterprise Value 18.23b)
FCF Margin = 25.44% (FCF TTM 1.80b / Revenue TTM 7.08b)
Net Margin = 20.54% (Net Income TTM 1.46b / Revenue TTM 7.08b)
Gross Margin = 41.28% ((Revenue TTM 7.08b - Cost of Revenue TTM 4.16b) / Revenue TTM)
Gross Margin QoQ = 41.08% (prev 38.10%)
Tobins Q-Ratio = 1.29 (Enterprise Value 18.23b / Total Assets 14.09b)
Interest Expense / Debt = 1.04% (Interest Expense 41.0m / Debt 3.95b)
Taxrate = 17.77% (107.0m / 602.0m)
NOPAT = 1.97b (EBIT 2.39b * (1 - 17.77%))
Current Ratio = 3.37 (Total Current Assets 2.98b / Total Current Liabilities 887.0m)
Debt / Equity = 0.82 (Debt 3.95b / totalStockholderEquity, last quarter 4.84b)
Debt / EBITDA = 0.60 (Net Debt 1.97b / EBITDA 3.29b)
Debt / FCF = 1.09 (Net Debt 1.97b / FCF TTM 1.80b)
Total Stockholder Equity = 4.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.56% (Net Income 1.46b / Total Assets 14.09b)
RoE = 29.95% (Net Income TTM 1.46b / Total Stockholder Equity 4.86b)
RoCE = 29.66% (EBIT 2.39b / Capital Employed (Equity 4.86b + L.T.Debt 3.21b))
RoIC = 24.95% (NOPAT 1.97b / Invested Capital 7.89b)
WACC = 5.57% (E(16.27b)/V(20.22b) * Re(6.72%) + D(3.95b)/V(20.22b) * Rd(1.04%) * (1-Tc(0.18)))
Discount Rate = 6.72% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -9.50%
[DCF] Terminal Value 84.48% ; FCFF base≈1.78b ; Y1≈1.51b ; Y5≈1.14b
[DCF] Fair Price = 213.5 (EV 34.78b - Net Debt 1.97b = Equity 32.81b / Shares 153.7m; r=5.90% [WACC]; 5y FCF grow -18.69% → 2.90% )
EPS Correlation: -46.00 | EPS CAGR: -12.15% | SUE: 0.29 | # QB: 0
Revenue Correlation: -62.23 | Revenue CAGR: -10.75% | SUE: 2.46 | # QB: 1
EPS next Quarter (2026-06-30): EPS=2.64 | Chg7d=+0.458 | Chg30d=+0.440 | Revisions Net=+5 | Analysts=7
EPS current Year (2026-12-31): EPS=8.47 | Chg7d=+0.587 | Chg30d=+1.216 | Revisions Net=+8 | Growth EPS=-5.6% | Growth Revenue=-7.0%
EPS next Year (2027-12-31): EPS=6.72 | Chg7d=+0.490 | Chg30d=+0.669 | Revisions Net=+7 | Growth EPS=-20.7% | Growth Revenue=-3.1%
[Analyst] Revisions Ratio: +1.00 (5 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -0.7% (Discount Rate 7.9% - Earnings Yield 8.6%)
[Growth] Growth Spread = -7.4% (Analyst -8.1% - Implied -0.7%)
P/E Forward = 11.4679
P/S = 2.2965
P/B = 3.2018
P/EG = 3.4458
Revenue TTM = 7.08b USD
EBIT TTM = 2.39b USD
EBITDA TTM = 3.29b USD
Long Term Debt = 3.21b USD (from longTermDebt, last quarter)
Short Term Debt = 110.0m USD (from shortTermDebt, last quarter)
Debt = 3.95b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.97b USD (from netDebt column, last quarter)
Enterprise Value = 18.23b USD (16.27b + Debt 3.95b - CCE 1.98b)
Interest Coverage Ratio = 15.45 (Ebit TTM 2.39b / Interest Expense TTM 155.0m)
EV/FCF = 10.12x (Enterprise Value 18.23b / FCF TTM 1.80b)
FCF Yield = 9.88% (FCF TTM 1.80b / Enterprise Value 18.23b)
FCF Margin = 25.44% (FCF TTM 1.80b / Revenue TTM 7.08b)
Net Margin = 20.54% (Net Income TTM 1.46b / Revenue TTM 7.08b)
Gross Margin = 41.28% ((Revenue TTM 7.08b - Cost of Revenue TTM 4.16b) / Revenue TTM)
Gross Margin QoQ = 41.08% (prev 38.10%)
Tobins Q-Ratio = 1.29 (Enterprise Value 18.23b / Total Assets 14.09b)
Interest Expense / Debt = 1.04% (Interest Expense 41.0m / Debt 3.95b)
Taxrate = 17.77% (107.0m / 602.0m)
NOPAT = 1.97b (EBIT 2.39b * (1 - 17.77%))
Current Ratio = 3.37 (Total Current Assets 2.98b / Total Current Liabilities 887.0m)
Debt / Equity = 0.82 (Debt 3.95b / totalStockholderEquity, last quarter 4.84b)
Debt / EBITDA = 0.60 (Net Debt 1.97b / EBITDA 3.29b)
Debt / FCF = 1.09 (Net Debt 1.97b / FCF TTM 1.80b)
Total Stockholder Equity = 4.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.56% (Net Income 1.46b / Total Assets 14.09b)
RoE = 29.95% (Net Income TTM 1.46b / Total Stockholder Equity 4.86b)
RoCE = 29.66% (EBIT 2.39b / Capital Employed (Equity 4.86b + L.T.Debt 3.21b))
RoIC = 24.95% (NOPAT 1.97b / Invested Capital 7.89b)
WACC = 5.57% (E(16.27b)/V(20.22b) * Re(6.72%) + D(3.95b)/V(20.22b) * Rd(1.04%) * (1-Tc(0.18)))
Discount Rate = 6.72% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -9.50%
[DCF] Terminal Value 84.48% ; FCFF base≈1.78b ; Y1≈1.51b ; Y5≈1.14b
[DCF] Fair Price = 213.5 (EV 34.78b - Net Debt 1.97b = Equity 32.81b / Shares 153.7m; r=5.90% [WACC]; 5y FCF grow -18.69% → 2.90% )
EPS Correlation: -46.00 | EPS CAGR: -12.15% | SUE: 0.29 | # QB: 0
Revenue Correlation: -62.23 | Revenue CAGR: -10.75% | SUE: 2.46 | # QB: 1
EPS next Quarter (2026-06-30): EPS=2.64 | Chg7d=+0.458 | Chg30d=+0.440 | Revisions Net=+5 | Analysts=7
EPS current Year (2026-12-31): EPS=8.47 | Chg7d=+0.587 | Chg30d=+1.216 | Revisions Net=+8 | Growth EPS=-5.6% | Growth Revenue=-7.0%
EPS next Year (2027-12-31): EPS=6.72 | Chg7d=+0.490 | Chg30d=+0.669 | Revisions Net=+7 | Growth EPS=-20.7% | Growth Revenue=-3.1%
[Analyst] Revisions Ratio: +1.00 (5 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -0.7% (Discount Rate 7.9% - Earnings Yield 8.6%)
[Growth] Growth Spread = -7.4% (Analyst -8.1% - Implied -0.7%)